Suppr超能文献

用于鉴定慢性肾衰竭致敏患者人白细胞抗原抗体特异性的单抗原流动微球

Single antigen flow beads for identification of human leukocyte antigen antibody specificities in hypersensitized patients with chronic renal failure.

作者信息

Soyöz Mustafa, Kılıçaslan-Ayna Tülay, Özkızılcık-Koçyiğit Aslı, Güleç Derya, Pirim İbrahim

机构信息

Department of Medical Biology and Genetics, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, İzmir, Turkey.

Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, İzmir, Turkey.

出版信息

Cent Eur J Immunol. 2016;41(1):93-100. doi: 10.5114/ceji.2015.56964. Epub 2016 Jan 20.

Abstract

AIMS OF THIS STUDY

Aims of this study were to identify class I and class II antibodies in highly sensitized patients by flow cytometry single antigen bead (FC-SAB) assay and to evaluate according to donor HLA type in order to increase their kidney transplantation chance.

MATERIAL AND METHODS

We analyzed 60 hypersensitive patients of 351 individuals, who applied to our laboratory for PRA test in November 2013-December 2014. Flow cytometric PRA screening and single antigen bead commercial kits were used for these analyses.

RESULTS

In our study group, 19 (31.7%) of these patients were male while 41 (68.3%) patients were female. The most common acceptable antigens were A02 (10.11%), HLA-A23 (10.11%), HLA-B38 (8.79%) and HLA-DRB103 (7.83%) in hypersensitive patients. The highest antibody reactivity on SAB was observed against HLA-A25, HLA-B45, HLA-DRB104 and HLA-DRB108 antigens.

CONCLUSIONS

The determination of these acceptable and unacceptable antigens may increase their transplantation chance. Pre-transplant HLA antibody identifications provide prognostic information with respect to the determination of patients who are at increased risk of graft loss.

摘要

本研究目的

本研究旨在通过流式细胞术单抗原微珠(FC-SAB)检测,识别高度致敏患者中的Ⅰ类和Ⅱ类抗体,并根据供体HLA类型进行评估,以增加其肾移植机会。

材料与方法

我们分析了2013年11月至2014年12月期间向我们实验室申请PRA检测的351例个体中的60例超敏患者。这些分析采用流式细胞术PRA筛查和单抗原微珠商业试剂盒。

结果

在我们的研究组中,这些患者中有19例(31.7%)为男性,41例(68.3%)为女性。超敏患者中最常见的可接受抗原为A02(10.11%)、HLA-A23(10.11%)、HLA-B38(8.79%)和HLA-DRB103(7.83%)。在SAB上观察到的最高抗体反应性是针对HLA-A25、HLA-B45、HLA-DRB104和HLA-DRB108抗原。

结论

确定这些可接受和不可接受的抗原可能会增加他们的移植机会。移植前HLA抗体鉴定为确定移植丢失风险增加的患者提供了预后信息。

相似文献

本文引用的文献

5
Management of the highly sensitized patient.高度致敏患者的管理。
Curr Opin Immunol. 2009 Oct;21(5):569-72. doi: 10.1016/j.coi.2009.07.010. Epub 2009 Aug 12.
10
Transplanting the highly sensitized patient: The emory algorithm.高敏患者的移植:埃默里算法
Am J Transplant. 2006 Oct;6(10):2307-15. doi: 10.1111/j.1600-6143.2006.01521.x. Epub 2006 Aug 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验